Proteostasis Therapeutics, Inc.
(NASDAQ : PTI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.57%183.821.3%$480.29m
ARRYArray BioPharma Inc.
0.13%46.568.1%$427.04m
CELGCelgene Corporation
0.36%98.181.3%$407.50m
GILDGilead Sciences, Inc.
0.37%68.510.9%$394.96m
BIIBBiogen Inc.
0.58%235.251.3%$352.72m
ILMNIllumina, Inc.
1.37%356.763.5%$286.08m
REGNRegeneron Pharmaceuticals, Inc.
3.15%320.622.6%$240.74m
VRTXVertex Pharmaceuticals Incorporated
0.67%182.961.9%$218.15m
AAgilent Technologies, Inc.
0.20%72.791.6%$195.60m
EXASExact Sciences Corporation
-0.63%115.2624.1%$187.97m
ALXNAlexion Pharmaceuticals, Inc.
3.64%128.282.0%$184.46m
BMRNBioMarin Pharmaceutical Inc.
1.51%86.304.3%$129.76m
SRPTSarepta Therapeutics, Inc.
-2.67%130.8314.7%$109.38m
INCYIncyte Corporation
2.05%86.612.5%$108.62m
MRTXMirati Therapeutics Inc.
3.41%104.682.5%$101.75m

Company Profile

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.